Association of OAZ1 gene polymorphisms with subclinical and clinical vascular events

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 10, 2007, Pages 2120-2126

  Dumont, Julie ^a,b,c   Zureik, Mahmoud ^a,b,c   Bauters, Christophe ^a,b,c,e   Grupposo, Marie Catherine ^a,b,c   Cottel, Dominique ^a,b,c   Montaye, Michèle ^a,b,c   Hamon, Martial ^f   Ducimetière, Pierre ^a,d   Amouyel, Philippe ^a,b,c   Brousseau, Thierry ^a,b,c  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d Paris Sud   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Common carotid intima media thickness; Coronary heart disease; Coronary in stent restenosis; Gene mutations; Ornithine decarboxylase antizyme 1

Indexed keywords

ANTIZYME; POLYAMINE; PROTEIN;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTERY INTIMA PROLIFERATION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY RISK; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYAMINE METABOLISM; PRIORITY JOURNAL; RESTENOSIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; AGED; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CELL PROLIFERATION; CORONARY ARTERY DISEASE; ENZYMOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER;

AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CELL PROLIFERATION; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ODDS RATIO; PHENOTYPE; POLYAMINES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK ASSESSMENT; RISK FACTORS;

EID: 35148817779     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.150458     Document Type: Article

References (31)

1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
2. Hoffmann R, Mintz GS. Coronary in-stent restenosis - predictors, treatment and prevention. Eur Heart J. 2000;21:1739-1749.
3. Vazquez-Padron RI, Lasko D, Li S, Louis L, Pestana IA, Pang M, Liotta C, Fornoni A, Aitouche A, Pham SM. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice. J Vasc Surg. 2004;40:1199-1207.
4. Bettuzzi S, Davalli P, Astancolle S, Pinna C, Roncaglia R, Boraldi F, Tiozzo R, Sharrard M, Corti A. Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts. FEBS Lett. 1999;446:18-22.
5. Durante W, Liao L, Peyton KJ, Schafer AI. Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression. Circ Res. 1998;83:217-223.
6. Liang M, Ekblad E, Hellstrand P, Nilsson BO. Polyamine synthesis inhibition attenuates vascular smooth muscle cell migration. J Vasc Res. 2004;41:141-147.
7. Nishida K, Abiko T, Ishihara M, Tomikawa M. Arterial injury-induced smooth muscle cell proliferation in rats is accompanied by increase in polyamine synthesis and level. Atherosclerosis. 1990;83:119-125.
8. Thyberg J, Fredholm BB. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Exp Cell Res. 1987;170:160-169.
9. Charollais RH, Mester J. Resumption of cell cycle in BALB/c-3T3 fibroblasts arrested by polyamine depletion: relation with " competence" gene expression. J Cell Physiol. 1988;137:559-564.
10. Bauer PM, Buga GM, Ignarro LJ. Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide. Proc Natl Acad Sci U S A. 2001;98:12802-12807.
11. Coffino P. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol. 2001;2:188-194.
12. Murakami Y, Matsufuji S, Miyazaki Y, Hayashi S. Forced expression of antizyme abolishes ornithine decarboxylase activity, suppresses cellular levels of polyamines and inhibits cell growth. Biochem J. 1994;304:183-187.
13. Mitchell JL, Leyser A, Holtorff MS, Bates JS, Frydman B, Valasinas AL, Reddy VK, Marton LJ. Antizyme induction by polyamine analogues as a factor of cell growth inhibition. Biochem J. 2002;366:663-671.
14. Tsuji T, Todd R, Meyer C, McBride J, Liao PH, Huang MF, Chou MY, Donoff RB, Wong DT. Reduction of ornithine decarboxylase antizyme (ODC-Az) level in the 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis model. Oncogene. 1998;16:3379-3385.
15. Jung MH, Kim SC, Jeon GA, Kim SH, Kim Y, Choi KS, Park SI, Joe MK, Kimm K. Identification of differentially expressed genes in normal and tumor human gastric tissue. Genomics. 2000;69:281-286.
16. Newman RM, Mobascher A, Mangold U, Koike C, Diah S, Schmidt M, Finley D, Zetter BR. Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem. 2004;279:41504-41511.
17. Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M, Amouyel P. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis. Eur Heart J. 2002;23:721-725.
18. Amant C, Bauters C, Bodart JC, Lablanche JM, Grollier G, Danchin N, Hamon M, Richard F, Helbecque N, McFadden EP, Amouyel P, Bertrand ME. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997;96:56-60.
19. Bauters C, Banos JL, Van Belle E, Mc Fadden EP, Lablanche JM, Bertrand ME. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation. 1998;97:318-321.
20. Bonithon-Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D, Ducimetiere P. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol. 1996;16:310-316.
21. Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetiere P. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke. 1996;27:654-660.
22. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J. 1997;18:1569-1582.
23. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
24. Ellis LA, Taylor CF, Taylor GR. A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning. Hum Mutat. 2000;15:556-564.
25. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet. 2004;68:165-177.
26. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
27. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation. 1998;98:82-89.
28. Korshunov VA, Berk BC. Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol. 2003;23:2185-2191.
29. Schwartz SM, deBlois D, O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
30. Schwartz SM, Virmani R, Rosenfeld ME. The good smooth muscle cells in atherosclerosis. Curr Atheroscler Rep. 2000;2:422-429.
31. Li M, Kuivenhoven JA, Ayyobi AF, Pritchard PH. T->G or T->A mutation introduced in the branchpoint consensus sequence of intron 4 of lecithin:cholesterol acyltransferase (LCAT) gene: intron retention causing LCAT deficiency. Biochim Biophys Acta. 1998;1391:256 -264.